BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1964820)

  • 1. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
    Galpern WR; Miller LG; Greenblatt DJ; Shader RI
    Br J Pharmacol; 1990 Dec; 101(4):839-42. PubMed ID: 1964820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
    Byrnes JJ; Miller LG; Greenblatt DJ; Shader RI
    Psychopharmacology (Berl); 1993; 111(1):91-5. PubMed ID: 7870939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.
    Miller LG; Woolverton S; Greenblatt DJ; Lopez F; Roy RB; Shader RI
    Biochem Pharmacol; 1989 Nov; 38(21):3773-7. PubMed ID: 2557030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.
    Miller LG; Greenblatt DJ; Barnhill JG; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):170-6. PubMed ID: 2839660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging.
    Miller LG; Lumpkin M; Galpern WR; Greenblatt DJ; Shader RI
    J Neurochem; 1991 Apr; 56(4):1241-7. PubMed ID: 1848276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benzodiazepine administration: from the patient to the gene.
    Miller LG
    J Clin Pharmacol; 1991 Jun; 31(6):492-5. PubMed ID: 1652596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1992 Apr; 261(1):285-9. PubMed ID: 1313872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
    Miller LG; Greenblatt DJ; Roy RB; Summer WR; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):177-82. PubMed ID: 2455789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration.
    Kang I; Miller LG
    Br J Pharmacol; 1991 Jun; 103(2):1285-7. PubMed ID: 1653067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo.
    Kaplan GB; Cotreau MM; Greenblatt DJ
    J Pharm Pharmacol; 1992 Aug; 44(8):700-3. PubMed ID: 1359103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    Allan AM; Baier LD; Zhang X
    J Pharmacol Exp Ther; 1992 May; 261(2):395-402. PubMed ID: 1374467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine.
    Galpern WR; Miller LG; Greenblatt DJ; Szabo GK; Browne TR; Shader RI
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S99-104. PubMed ID: 1662953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of GABAA receptor function by chronic exposure to GABA-neutral and GABA-negative benzodiazepine ligands in cultured cortical neurons.
    Miller LG; Heller J; Lumpkin M; Weill CL; Greenblatt DJ; Shader RI
    Biochem Pharmacol; 1990 Sep; 40(6):1337-44. PubMed ID: 2169744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lorazepam tolerance and withdrawal on GABAA receptor operated chloride channels in mice selected for differences in ethanol withdrawal severity.
    Allan AM; Baier LD; Zhang X
    Life Sci; 1992; 51(12):931-43. PubMed ID: 1381457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations.
    Miller LG; Galpern WR; Greenblatt DJ; Lumpkin M; Shader RI
    J Pharmacol Exp Ther; 1990 Jul; 254(1):33-8. PubMed ID: 2164100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute administration of alcohol on in vivo binding of [3H]Ro 15-1788 to mouse brain.
    Mosaddeghi M; Burke TF; Moerschbaecher JM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):639-45. PubMed ID: 1331409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.
    Burke TF; Miller LG; Moerschbaecher JM
    Pharmacol Biochem Behav; 1994 May; 48(1):69-76. PubMed ID: 7913233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic low-dose alprazolam augments gamma-aminobutyric acid(A) receptor function.
    Lopez F; Miller LG; Greenblatt DJ; Schatzki A; Lumpkin M; Shader RI
    J Clin Psychopharmacol; 1992 Apr; 12(2):119-23. PubMed ID: 1315342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal lorazepam administration is associated with GABAA receptor alterations in late embryonic and mature chicks.
    Miller LG; Weill CL; Roy RB
    Neurotoxicology; 1989; 10(3):517-22. PubMed ID: 2560535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and receptor binding changes during chronic lorazepam administration.
    Fahey JM; Pritchard GA; Grassi JM; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 2001; 69(1-2):1-8. PubMed ID: 11420062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.